MONROVIA, CA, August 19, 2009
/24-7PressRelease/ -- Given the high drug attrition rates and the declining number of new chemical entities turned into approved medicines, there exists an urgent need to increase the effectiveness and probability of success of the classical drug discovery process. An alarming statistics in drug development indicate that the average success rate for all therapeutic areas is approximately 11% and only 1 in 9 compounds makes it through development to get approved by the regulatory agencies. There exists an urgent need to increase the effectiveness and probability of success of the pharmaceutical industry by integrating biomarkers in early development. Translational medicine became an essential component of this effort and is one of the largest growing areas of drug discovery and development.
For these reasons the field of Translational Medicine is of continuously escalating significance. The Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference will be held October 14-16, 2009 in San Diego, CA. The conference covers a wide range of topics in the field, from the new technologies facilitating biomarker discovery and the identification of safety biomarkers used to measure toxicity in vital organs, to the development of more predictive pre-clinical models and the discussion of partnering opportunities in translational medicine. This conference offers scientists, clinicians, medical practitioners and specialists, students, R&D experts and patients the opportunity to meet and discuss the latest breakthroughs and advances in the field of biomarkers and translational medicine.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
- biotech, clinical, conferences, epimiology, evidence-based, gtcbio, interventional, medicine, research, translational, trials
Read more Press Releases from Rania Hafez:- Allergan and CMO at Altheos to speak at Ocular Drug Discovery conference Feb 27-28, 2012 Las Vegas
- AstraZeneca, GSK to speak at Anti-infectives Partnering meeting Nov 7-8, Boston
- Glenn D. Prestwich to speak at 7th Modern Drug Discovery Summit Oct 19-21 2011 in San Diego, CA
- Vice President at Johnson and Johnson to speak at Modern Drug Summit Oct 19-21 2011 in San Diego, CA
- Biosimilars and FDA talk at 4th Protein Discovery & Therapeutics Conference Oct 19-21 in San Diego
- Dr. Joseph Joyce, Director At Merck & Co., To Speak At Vaccines Meeting On Nov. 7-8 In Boston, MA.
- Klarquist Sparkman to speak at 4th Protein Discovery & Therapeutics Meeting Oct 19-21 in San Diego
- Dr. Philip Dormitzer, Head at Novartis, to Speak at Vaccines Meeting on Nov. 7-8 in Boston, MA
- Klaus Mendla, Global Head at Boehringer to speak at CNS Partnering meeting Sept 22-23, San Francisco
- Dr. Kanta Subbarao, Chief at the NIH, to speak at vaccines meeting on Nov. 7-8 in Boston, MA
Other Press Release Headlines:
